Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
Authors
Keywords
-
Journal
Nature Communications
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-03-18
DOI
10.1038/ncomms4462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of metallomics and proteomics to study the effects of the metallodrug RAPTA-T on human cancer cells
- (2012) Dirk A. Wolters et al. Metallomics
- The mechanics behind DNA sequence-dependent properties of the nucleosome
- (2012) Eugene Y. D. Chua et al. NUCLEIC ACIDS RESEARCH
- A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
- (2011) Bin Wu et al. CHEMISTRY-A EUROPEAN JOURNAL
- Metal-based antitumour drugs in the post-genomic era: what comes next?
- (2011) Gianni Sava et al. DALTON TRANSACTIONS
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
- (2011) Michael Groessl et al. Metallomics
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation
- (2011) Bin Wu et al. NUCLEIC ACIDS RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Nucleosome structural studies
- (2010) Song Tan et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
- (2010) Petra Heffeter et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Performance of Molecular Mechanics Force Fields for RNA Simulations: Stability of UUCG and GNRA Hairpins
- (2010) Pavel Banáš et al. Journal of Chemical Theory and Computation
- Organometallic ruthenium-based antitumor compounds with novel modes of action
- (2010) Wee Han Ang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells
- (2009) Mai Quynh Thanh Tran et al. ANALYTICAL BIOCHEMISTRY
- Inhibition of transcription by platinum antitumor compounds
- (2009) Ryan C. Todd et al. Metallomics
- DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent
- (2009) Gabriela E. Davey et al. NUCLEIC ACIDS RESEARCH
- Chromatin - a New, Old Drug Target?
- (2008) Gabriela E. Davey et al. Chemical Biology & Drug Design
- Hydrolysis study of the bifunctional antitumour compound RAPTA-C, [Ru(η6-p-cymene)Cl2(pta)]
- (2008) Claudine Scolaro et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Determination of Alkali and Halide Monovalent Ion Parameters for Use in Explicitly Solvated Biomolecular Simulations
- (2008) In Suk Joung et al. JOURNAL OF PHYSICAL CHEMISTRY B
- DNA Structural Distortions Induced by Ruthenium−Arene Anticancer Compounds
- (2008) Christian Gossens et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search